About Company
- Legal Name: Gan & Lee Pharmaceuticals
- Registered country: China
- Address: No. 8 Nanfeng West 1st Street, Huoxian, Tongzhou District, Beijing 101109, China • Beijing
- Established year: 1998
Description:
Gan & Lee Pharmaceuticals, established in 1998, manufactures finished dosage pharmaceutical products under OEM and its own brand, offering CMO contract manufacturing. The company sells across Central/South America, Asia, the Middle East, North America, and Africa, and is recognized for its international certifications, experienced R&D staff, production capacity, broad product line, and strong reputation for quality service.
Business Activities
Biopharmaceutical Products
Manufacturer
Drug Delivery Systems
Medical Device Manufacturer
Finished Dosage Forms
Manufacturer
Manufacturing Equipment & Utilities
Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Afghanistan
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Key Products/Services
- Finished Dosage Forms: Rapilin® 30(insulin aspart 30 injection), Basalin®(insulin glargine injeciton), Prandilin™ 25(insulin lispro 25 injection), Prandilin™(insulin lispro injection), Rapilin®(insulin aspart injection), Similin® 30(insulin human 30 injection), Diabetes medicines
- Manufacturing Equipment & Utilities: pre-filled pen parts(disposable)
- Drug Delivery Systems: GanleePen™(reusable insulin pen)
Our Products & Services
Sell · Manufacturing Equipment & Utilities
Sell · Medical Devices & Equipment
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment